# Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome

> **NCT00977171** · PHASE2 · TERMINATED · sponsor: **Chelsea Therapeutics** · enrollment: 3 (actual)

## Conditions studied

- Chronic Fatigue Syndrome
- Orthostatic Hypotension
- Neurally Mediated Hypotension
- Neurogenic Orthostatic Hypotension

## Interventions

- **DRUG:** Droxidopa

## Key facts

- **NCT ID:** NCT00977171
- **Lead sponsor:** Chelsea Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Enrollment issues.
- **Last updated:** 2014-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00977171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00977171, "Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00977171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*